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Abstract
The cost of DNA sequencing is decreasing year by year, and the era of personalized medicine and the
$1000 genome seems to be just around the corner. In order to link genetic variation to gene function,
however, we need to learn more about the function of the non-coding genomic elements. The advance of
high-throughput sequencing enabled rapid progress in mapping the functional elements in our genome. In
the present article, I discuss how intronic mutations acting at Alu elements enable formation of new exons.
I review the mutations that cause disease when promoting a major increase in the inclusion of Alu exon into
mature transcripts. Moreover, I present the mechanism that represses such a major inclusion of Alu exons
and instead enables a gradual evolution of Alu elements into new exons.
The regulatory arsenal of the non-coding
genome
The non-coding sequence (i.e. the sequence that does not
code for proteins) represents 98% of our genome. The
primary function of this enormous portion of our genome
is to contain a vast resource of regulatory elements that
control gene expression. This includes the promoter and
enhancer elements for transcriptional regulation, and a variety
of diverse elements that are needed for post-transcriptional
regulation of gene expression. This second class of regulatory
elements is located mainly in introns of pre-mRNAs or in the
untranslated regions ofmRNAs, where it controls the diverse
post-transcriptional processes, including RNA editing or
modification (such as methylation), alternative splicing, 3′
end processing, mRNA localization, translation and decay.
Together, the arsenal of regulatory elements within the non-
coding portion of the genome allows the fine-balanced gene
expression appropriate to each cell type in our body, and
enables these cells to respond appropriately to the diverse
developmental and environmental stimuli.
The evolutionary potential hidden within
introns
Introns represent 23% of the sequence of human genome.
Many important non-coding RNAs, such as miRNAs and
snoRNAs (small nucleolar RNAs), are expressed from
introns. Moreover, introns are a rich resource of regulatory
elements, which can bind to diverse RBPs (RNA-binding
proteins). Many diverse RBPs bind these intronic elements,
most often to repress recognition of nearby splice sites [1].
These elements regulate splicing of alternative exons, but they
Key words: alternative splicing, Alu element, disease, evolution, intron, transposable element.
Abbreviations used: hnRNP, heterogeneous nuclear ribonucleoprotein; iCLIP, individual
nucleotide resolution cross-linking and immunoprecipitation; PTS, 6-pyruvoyltetrahydropterin
synthase; RBP, RNA-binding protein.
1email j.ule@ucl.ac.uk
are also important to repress splicing from the vast array
of cryptic splicing elements that are dispersed throughout
introns. The cryptic splicing elements are in a poised state:
they do not normally contribute to splicing, but even subtle
mutations can convert them into active splicing elements.
Interestingly, one of the primary sources of cryptic splicing
elements are transposable elements [2].
The role of transposable elements in gene
regulation
Some 42% of the human genome is made of transposable ele-
ments [3]. These elements have profound effects on genome
structure and function. They can mediate structural changes,
for instance by promoting DNA recombination. Moreover,
they can affect expression of nearby genes in numerous
ways, by acting as transcriptional enhancers or silencers, as
regulators of translation, or as a source of new sites for pre-
mRNA processing. Their evolutionary importance is clear
from the finding that transposable elements reshaped the
human transcriptional landscape by contributing hundreds
of thousands of novel regulatory elements to the primate
lineage [3,4]. In the present article, I review the importance
of Alu elements, the most common transposable element in
the primate genomes, in the formation of new exons.
Alu elements as a source of new exons
Alu elements are retrotransposable elements that have
originated from the small cytoplasmic 7SL RNA. The event
when a copy of the 7SL RNA became a precursor of the Alu
elements took place early in the evolution of supraprimates
[5]. Alu elements occur in large numbers in primate genomes
and comprise over 10% of the human genome. Over 650000
Alu elements reside in the introns of protein-coding genes.
When inserted in an antisense orientation, an Alu element
contains several cryptic splice sites, and is therefore an
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excellent template for the production of new exons. Thus the
human genome contains a large reservoir ofAlu elements that
can turn into exons. Indeed, approximately 5% of internal
alternative exons in the human transcriptome originate from
Alu elements [6].
Importantly, some of these exonized Alu elements are
unique to the humangenome, or are spliced in a tissue-specific
manner only in humans. For instance, anAlu-derived exon in
the SEPN1 (selenoprotein N1) gene is under tissue-specific
control in humans. In contrast with chimpanzees, where it is
aminormRNA isoform in all tissues, theAlu-derived SEPN1
exon is part of the dominantmRNA isoform in humanmuscle
tissue [7]. It is clear that exonization of Alu elements played
an important role in primate evolution [2].
Controlling the emergence of Alu exons
When they initially turn into exons, Alu elements generally
introduce premature stop codons, leading to mRNA
degradation or aberrant proteins [8]. Thus, if new Alu
elements became part of the dominant mRNA isoform, they
would almost invariably be deleterious for the cell. It is
therefore not surprising that our cells employ a specific RBP
to repress aberrant incorporation of deleterious Alu exons
into mature transcripts.
The mechanism protecting the transcriptome from
aberrant exonization of Alu elements was revealed by
the iCLIP (individual nucleotide resolution cross-linking
and immunoprecipitation) technique, which documents the
protein–RNA interactions that take place inside living cells
[9]. Quantitative analysis of genome-wide binding profiles
revealed that two RBPs compete for binding to the antisense
Alu elements, and thereby control the emergence of new Alu
exons. The first of these proteins is hnRNP (heterogeneous
nuclear ribonucleoprotein) C, an abundant nuclear RBP that
binds to uridine tracts that are present within the antisense
Alu elements. A quarter of hnRNP C binding maps to Alu
elements. Strikingly, depletion of hnRNP C leads to aberrant
exonizations of Alu elements in over 1000 transcripts [8].
The explosion of newAlu exons upon depletion of hnRNP
C revealed that thousands of antisense Alu elements are in a
poised state, such that removal of a single RBP is sufficient
for exonization. How does hnRNP C manage to keep a
lid on the steaming pot of Alu elements? The answer was
provided by a quantitative iCLIP analysis of U2AF65, an
RBP that binds to 3′ splice sites and thereby initiates the
splicing process. Analysis of the genome-wide U2AF65-
binding profile demonstrated thatU2AF65 gains access to the
uridine tracts within antisense Alu elements upon removal of
hnRNP C from the cells. Thus hnRNP C acts by competing
with U2AF65 for binding to the antisense Alu elements, and
thereby prevents the recognition of cryptic 3′ splice sites [8].
Alu exons in disease
Activation of cryptic exons can lead to diverse human genetic
diseases. Approximately 25% of these are caused by aberrant
activation of cryptic exons from antisense Alu elements [10].
Mutations that remove hnRNP C-dependent repression can
cause the activation of Alu exons. An example of this process
is evident in the mutation within the Alu element of the PTS
(6-pyruvoyltetrahydropterin synthase) gene. PTS is required
for the biosynthesis of tetrahydrobiopterin, also known as
BH4, an essential cofactor and regulator of enzymes involved
in serotonin biosynthesis and nitric oxide synthase activity.
Mutations in PTS result in hyperphenylalaninaemia [11].
Splicing reporter assays demonstrated that one of the
disease-causing mutations removes the uridine tract from
Alu elements, which is required for hnRNP C binding. This
allows binding of U2AF65 to the Alu element, leading to
activation of a new 3′ splice site, and a deleterious Alu exon
that becomes part of the dominant transcript (Figure 1). The
resulting transcript contains a premature stop codon, and
is therefore targeted for degradation, whereas the original
isoform required for production of the full-length protein is
lost [8].
Evolution: the path trodden with baby
steps
Without hnRNP C binding, many intronic Alu elements
immediately turn into exons and thereby severely damage
the resident gene. Therefore mutations can convert an Alu
element into a dominant exon when completely removing
hnRNPCbinding, which can lead to disease.However, this is
just an extreme case in the diverse spectrum of mutations that
canmodulate the formationofAlu exons.Asdemonstratedby
the splicing reporter assays, point mutations within uridine
tractsmodify the competitive binding between hnRNPCand
U2AF65 in a subtle way, and thereby lead to only a minor
change in the exonization of the corresponding Alu element
[8]. Thus the competitive binding of hnRNP C and U2AF65
can be modulated via sequential mutations, which gradually
increase the binding of U2AF65.
The hnRNP C/U2AF65 regulatory mechanism ensures
that evolution of new exons from Alu elements occurs via
an incremental process. Mutations can promote formation
of Alu exons either by modifying the competitive binding of
U2AF65 andhnRNPC, or by increasing the strength of splice
sites within Alu elements, or act on additional enhancer or
silencer elements [2]. A subtle increase in the inclusion ofAlu
exon does not perturb the expression of the normal mRNA
isoform, therefore there is little negative selection pressure
to remove the new mRNA isoform containing the Alu exon.
This enables additional mutations to accumulate within the
Alu exon itself, which can remove the premature stop codons
and change the coding potential of the exon. Each mutation
can thus make a small step towards ultimately creating anAlu
exonwith a novel and beneficial function for the cell [8]. Thus
hnRNP C enables exonization of Alu exons to proceed in
small steps, without hampering the expression of the primary
mRNA isoform. In other words, evolution treads the path of
Alu exons with baby steps in order to minimize the chance
that a new Alu exon would cause disease.
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Figure 1 hnRNP C repression of Alu exonization in the PTS gene is relevant for disease
(A) A view of the exon/intron structure of the PTS gene. The boxes below show the positions of short interspersed elements
(SINE), which include Alu elements, as deﬁned by RepeatMasker. (B) The disease-relevant Alu element within the PTS gene
is shown at greater resolution. The position of the two exons that can emerge from this Alu element are schematically
indicated: the blank exon is rarely included in the wild-type (WT) cells, whereas the grey exon is part of the dominant isoform
in disease. Below, the sequence is shown in a colour-coded fashion. The uridine tracts (in red) bind to hnRNP C, which
represses binding of U2AF65. (C) The two 3′ splice sites that can lead to the formation of Alu exon are shown at nucleotide
resolution. In wild-type cells, hnRNP C binds to the long uridine tracts to repress the binding of U2AF65, and therefore the
3′ splice site marked by the open arrowhead is rarely used. In disease, the primary hnRNP C-binding site is deleted, and
therefore U2AF65 can bind to the pyrimidine tract upstream of the 3′ splice site that is marked by the grey arrowhead. This
leads to strong inclusion of the grey exon that is shown in (B) [8].
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Conclusion
The beauty of evolution is in its ability to fine-tune the
cellular function in the face of changing environment,without
thereby damaging the core cellularmechanisms. The carefully
regulated exonization of Alu exons enables the evolutionary
path to be taken in small reversible steps. The formation of
Alu exons thus provides an example of how the fine-balanced
mechanisms can act tominimize the chance that diseasewould
occur as a side effect of evolutionary processes. Nevertheless,
the core mechanisms in our cells are very complex, therefore
it is inevitable that the evolutionary process will occasionally
make a step too large, anddisrupt the primarymRNAisoform
in a manner that will cause disease.
Alu elements are one of the many different types of
elements hidden within introns, which enable evolution to
seek new solutions by creating alternative mRNA isoforms
without destroying the primary mRNA isoform. It is most
likely that many other RBPs play a role similar to hnRNP
C, ensuring that creation of new exons follows a gradual
process, instead of a sudden activation of cryptic exons that is
likely to cause genetic disease. Further application of genomic
technologies and new computational tools will facilitate the
discovery of the intronic hotspots where mutations can lead
either to disease or to the evolution of new exons.
Apart from producing new exons, transposable elements
can modulate the transcriptome in additional ways. In
DNA, transposable elements can interact withDNA-binding
proteins to change the transcription of nearby genes, and in
RNA, they can change the structure of RNA, influence 3′ end
processing, or mRNA localization or translation [3]. Similar
to the hnRNP C-dependent repression of Alu exons, cells
contain diversemechanisms to buffer the uncontrolled effects
of transposable elements on transcriptome. This includes
DNA methylation, RNA editing, nuclear mRNA retention
and RNAi-based silencing [12]. All of these mechanisms
may help to minimize the chance that transposable elements
would cause disease, but would instead enable evolutionary
exploration of changes in gene expression and new cellular
functions. Increased understanding of the interplay between
the transposable elements and the regulatorymachineryof the
cell will help us to better interpret the functional impact of
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SNPs (single nucleotide polymorphisms) and other types
of variation within the non-coding portion of our genome
[13].
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